A crucial aspect of regenerative healthcare and drug investigation lies in the ability to grow human stem cell populations to sufficient quantities for therapeutic uses. Traditionally, restricted cell availability posed a significant hindrance to progress in these fields. Consequently, considerable effort has been directed towards optimizing protoc